@article {6, editor = {,}, title = {â–¼Moclobemide for depression}, volume = {32}, number = {1}, pages = {6--8}, year = {1994}, doi = {10.1136/dtb.1994.3216}, publisher = {British Medical Journal Publishing Group}, abstract = {Relevant BNF section: 4.3.2Moclobemide (Manerix - Roche), the first of a new class of antidepressant drugs, was launched in the UK last year. It is a reversible inhibitor of monoamine oxidase A, which the manufacturer claims is a "first line treatment for major depression". Is this claim justified?}, issn = {0012-6543}, URL = {https://dtb.bmj.com/content/32/1/6}, eprint = {https://dtb.bmj.com/content/32/1/6.full.pdf}, journal = {Drug and Therapeutics Bulletin} }